web analytics

EPO – Finalist Industry – Drug against multi-resistant tuberculosis, Koen Andries, Jerome Guillemont

Invention: Drug against multi-resistant tuberculosis

Tuberculosis continues to claim more than 2 million lives annually. Even worse, the bacteria causing the disease are becoming increasingly resistant to existing medications. Enter a new anti-TB drug invented by Belgian researcher Koen Andries and team, a highly effective compound named bedaquiline that cuts off the energy supply in tuberculosis bacteria.

More 'EPO - European Patent Office' videos